{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:01:56Z","timestamp":1773054116549,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"DOI":"10.1038\/s41390-026-04823-w","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T07:33:28Z","timestamp":1773041608000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Global landscape of juvenile dermatomyositis research: a bibliometric analysis"],"prefix":"10.1038","author":[{"given":"Chun-Lung","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Chi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm","family":"Koo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"4823_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.55563\/clinexprheumatol\/56ilob","volume":"40","author":"LJ McCann","year":"2022","unstructured":"McCann, L. J., Livermore, P., Wilkinson, M. G. L. & Wedderburn, L. R. Juvenile dermatomyositis. Where are we now?. Clin. Exp. Rheumatol. 40, 394\u2013403 (2022).","journal-title":"Clin. Exp. Rheumatol."},{"key":"4823_CR2","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/B978-0-444-59565-2.00014-9","volume":"113","author":"P Quartier","year":"2013","unstructured":"Quartier, P. & Gherardi, R. K. Juvenile dermatomyositis. Handb. Clin. Neurol. 113, 1457\u20131463 (2013).","journal-title":"Handb. Clin. Neurol."},{"key":"4823_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4078\/jrd.2022.29.1.14","volume":"29","author":"JW Rhim","year":"2022","unstructured":"Rhim, J. W. Juvenile dermatomyositis. J. Rheum. Dis. 29, 14\u201321 (2022).","journal-title":"J. Rheum. Dis."},{"key":"4823_CR4","first-page":"822","volume":"49","author":"CM Ridley","year":"1956","unstructured":"Ridley, C. M. Juvenile dermatomyositis. Proc. R. Soc. Med. 49, 822\u2013823 (1956).","journal-title":"Proc. R. Soc. Med."},{"key":"4823_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/BOR.0000000000001112","volume":"37","author":"SL Coss","year":"2025","unstructured":"Coss, S. L., Sabbagh, S. E. & Kim, H. Updates in juvenile dermatomyositis: pathogenesis and therapy. Curr. Opin. Rheumatol. 37, 445\u2013456 (2025).","journal-title":"Curr. Opin. Rheumatol."},{"key":"4823_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/art.42768","volume":"76","author":"MA Sherman","year":"2024","unstructured":"Sherman, M. A. et al. Clinical features and immunogenetic risk factors associated with additional autoantibodies in anti-transcriptional intermediary factor 1\u03b3 juvenile-onset dermatomyositis. Arthritis Rheumatol. 76, 631\u2013637 (2024).","journal-title":"Arthritis Rheumatol."},{"key":"4823_CR7","doi-asserted-by":"publisher","first-page":"1166017","DOI":"10.3389\/fcell.2023.1166017","volume":"11","author":"X Chen","year":"2023","unstructured":"Chen, X., Lian, D. & Zeng, H. Single-cell profiling of peripheral blood and muscle cells reveals inflammatory features of juvenile dermatomyositis. Front. Cell Dev. Biol. 11, 1166017 (2023).","journal-title":"Front. Cell Dev. Biol."},{"key":"4823_CR8","doi-asserted-by":"publisher","unstructured":"Xiao, Y. et al. Multiomics analysis uncovers subtype-specific mechanisms and biomarkers in idiopathic inflammatory myopathies. Ann. Rheum. Dis. https:\/\/doi.org\/10.1016\/j.ard.2025.08.011 (2025).","DOI":"10.1016\/j.ard.2025.08.011"},{"key":"4823_CR9","doi-asserted-by":"publisher","first-page":"103353","DOI":"10.1016\/j.autrev.2023.103353","volume":"22","author":"MG Danieli","year":"2023","unstructured":"Danieli, M. G., Paladini, A., Longhi, E., Tonacci, A. & Gangemi, S. A machine learning analysis to evaluate the outcome measures in inflammatory myopathies. Autoimmun. Rev. 22, 103353 (2023).","journal-title":"Autoimmun. Rev."},{"key":"4823_CR10","doi-asserted-by":"publisher","first-page":"bbad514","DOI":"10.1093\/bib\/bbad514","volume":"25","author":"E McLeish","year":"2023","unstructured":"McLeish, E., Slater, N., Mastaglia, F. L., Needham, M. & Coudert, J. D. From data to diagnosis: how machine learning is revolutionizing biomarker discovery in idiopathic inflammatory myopathies. Brief. Bioinform. 25, bbad514 (2023).","journal-title":"Brief. Bioinform."},{"key":"4823_CR11","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1080\/1744666X.2018.1535901","volume":"14","author":"AM Huber","year":"2018","unstructured":"Huber, A. M. Update on the clinical management of juvenile dermatomyositis. Expert Rev. Clin. Immunol. 14, 1021\u20131028 (2018).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"4823_CR12","doi-asserted-by":"publisher","first-page":"101976","DOI":"10.1016\/j.berh.2024.101976","volume":"38","author":"SR Veldkamp","year":"2024","unstructured":"Veldkamp, S. R., van Wijk, F., van Royen-Kerkhof, A. & Jansen, M. H. Personalised medicine in juvenile dermatomyositis: from novel insights in disease mechanisms to changes in clinical practice. Best Pract. Res. Clin. Rheumatol. 38, 101976 (2024).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"4823_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12519-019-00313-8","volume":"16","author":"JQ Wu","year":"2020","unstructured":"Wu, J. Q., Lu, M. P. & Reed, A. M. Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment. World J. Pediatr. 16, 31\u201343 (2020).","journal-title":"World J. Pediatr."},{"key":"4823_CR14","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1080\/14656566.2024.2392021","volume":"25","author":"RS Wallwork","year":"2024","unstructured":"Wallwork, R. S., Paik, J. J. & Kim, H. Current evidence for janus kinase inhibitors in adult and juvenile dermatomyositis and key comparisons. Expert Opin. Pharmacother. 25, 1625\u20131645 (2024).","journal-title":"Expert Opin. Pharmacother."},{"key":"4823_CR15","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.3390\/en18102437","volume":"18","author":"E Marl\u00e9s-S\u00e1enz","year":"2025","unstructured":"Marl\u00e9s-S\u00e1enz, E., G\u00f3mez-Luna, E., Guerrero, J. M. & Vasquez, J. C. Innovative bibliometric methodology: a new big data-based framework for scientific research. Energies 18, 2437 (2025).","journal-title":"Energies"},{"key":"4823_CR16","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00296-022-05211-3","volume":"43","author":"M Li","year":"2023","unstructured":"Li, M. et al. Bibliometric and altmetric analyses of publication activity in the field of idiopathic inflammatory myopathy in 2011\u20132021 based on Web of Science core collection databases. Rheumatol. Int. 43, 1121\u20131133 (2023).","journal-title":"Rheumatol. Int."},{"key":"4823_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1190","volume":"12","author":"XN Ma","year":"2024","unstructured":"Ma, X. N. et al. A bibliometric analysis of the research status and trends in studies on polymyositis and dermatomyositis with interstitial lung disease from 2000 to 2022 using Web of Science. Immun. Inflamm. Dis. 12, e1190 (2024).","journal-title":"Immun. Inflamm. Dis."},{"key":"4823_CR18","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s11192-015-1798-9","volume":"106","author":"AW Harzing","year":"2016","unstructured":"Harzing, A. W. & Alakangas, S. Google Scholar, Scopus and the Web of Science: a longitudinal and cross-disciplinary comparison. Scientometrics 106, 787\u2013804 (2016).","journal-title":"Scientometrics"},{"key":"4823_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/publications9010012","volume":"9","author":"R Pranckut\u0117","year":"2021","unstructured":"Pranckut\u0117, R. Web of Science (WoS) and Scopus: the titans of bibliographic information in today\u2019s academic world. Publications 9, 12 (2021).","journal-title":"Publications"},{"key":"4823_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (first of two parts). N. Engl. J. Med. 292, 344\u2013347 (1975).","journal-title":"N. Engl. J. Med."},{"key":"4823_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (second of two parts). N. Engl. J. Med. 292, 403\u2013407 (1975).","journal-title":"N. Engl. J. Med."},{"key":"4823_CR22","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","volume":"11","author":"M Aria","year":"2017","unstructured":"Aria, M. & Cuccurullo, C. bibliometrix: an R-tool for comprehensive science mapping analysis. J. Informetr. 11, 959\u2013975 (2017).","journal-title":"J. Informetr."},{"key":"4823_CR23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","volume":"84","author":"NJ van Eck","year":"2010","unstructured":"van Eck, N. J. & Waltman, L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 84, 523\u2013538 (2010).","journal-title":"Scientometrics"},{"key":"4823_CR24","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1287\/mnsc.2015.2366","volume":"63","author":"RJ Funk","year":"2017","unstructured":"Funk, R. J. & Owen-Smith, J. A dynamic network measure of technological change. Manag. Sci. 63, 791\u2013817 (2017).","journal-title":"Manag. Sci."},{"key":"4823_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0313268","volume":"19","author":"M Li","year":"2024","unstructured":"Li, M., Livan, G. & Righi, S. Breaking down the relationship between disruption scores and citation counts. PLoS One 19, e0313268 (2024).","journal-title":"PLoS One"},{"key":"4823_CR26","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41586-019-0941-9","volume":"566","author":"L Wu","year":"2019","unstructured":"Wu, L., Wang, D. & Evans, J. A. Large teams develop and small teams disrupt science and technology. Nature 566, 378\u2013382 (2019).","journal-title":"Nature"},{"key":"4823_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","volume":"34","author":"R Morita","year":"2011","unstructured":"Morita, R. et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34, 108\u2013121 (2011).","journal-title":"Immunity"},{"key":"4823_CR28","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0140-6736(02)11279-7","volume":"360","author":"JM Gardner-Medwin","year":"2002","unstructured":"Gardner-Medwin, J. M., Dolezalova, P., Cummins, C. & Southwood, T. R. Incidence of Henoch-Sch\u00f6nlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 360, 1197\u20131202 (2002).","journal-title":"Lancet"},{"key":"4823_CR29","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/art.37754","volume":"65","author":"CV Oddis","year":"2013","unstructured":"Oddis, C. V. et al. Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum. 65, 314\u2013324 (2013).","journal-title":"Arthritis Rheum."},{"key":"4823_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJM198602063140601","volume":"314","author":"JT Kissel","year":"1986","unstructured":"Kissel, J. T., Mendell, J. R. & Rammohan, K. W. Microvascular deposition of complement membrane attack complex in dermatomyositis. N. Engl. J. Med. 314, 329\u2013334 (1986).","journal-title":"N. Engl. J. Med."},{"key":"4823_CR31","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1002\/art.22164","volume":"54","author":"IN Targoff","year":"2006","unstructured":"Targoff, I. N. et al. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 54, 3682\u20133689 (2006).","journal-title":"Arthritis Rheum."},{"key":"4823_CR32","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1002\/art.38093","volume":"65","author":"DF Fiorentino","year":"2013","unstructured":"Fiorentino, D. F. et al. Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1\u03b3. Arthritis Rheum. 65, 2954\u20132962 (2013).","journal-title":"Arthritis Rheum."},{"key":"4823_CR33","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1002\/acr.20532","volume":"63","author":"LG Rider","year":"2011","unstructured":"Rider, L. G. et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res. 63, S118\u2013S157 (2011).","journal-title":"Arthritis Care Res."},{"key":"4823_CR34","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/art.20849","volume":"52","author":"TD Levine","year":"2005","unstructured":"Levine, T. D. Rituximab in the treatment of dermatomyositis: an open-label pilot study. Arthritis Rheum. 52, 601\u2013607 (2005).","journal-title":"Arthritis Rheum."},{"key":"4823_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","volume":"82","author":"ME DeWane","year":"2020","unstructured":"DeWane, M. E., Waldman, R. & Lu, J. Dermatomyositis: clinical features and pathogenesis. J. Am. Acad. Dermatol. 82, 267\u2013281 (2020).","journal-title":"J. Am. Acad. Dermatol."},{"key":"4823_CR36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/art.11122","volume":"49","author":"EP Mendez","year":"2003","unstructured":"Mendez, E. P. et al. US incidence of juvenile dermatomyositis, 1995\u20131998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum. 49, 300\u2013305 (2003).","journal-title":"Arthritis Rheum."},{"key":"4823_CR37","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/rheumatology\/keg403","volume":"42","author":"N Ruperto","year":"2003","unstructured":"Ruperto, N. et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology 42, 1452\u20131459 (2003).","journal-title":"Rheumatology"},{"key":"4823_CR38","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1067\/mpd.2001.112473","volume":"138","author":"M Mukamel","year":"2001","unstructured":"Mukamel, M., Horev, G. & Mimouni, M. New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment. J. Pediatr. 138, 763\u2013766 (2001).","journal-title":"J. Pediatr."},{"key":"4823_CR39","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1542\/peds.59.2.212","volume":"59","author":"JC Jacobs","year":"1977","unstructured":"Jacobs, J. C. Methotrexate and azathioprine treatment of childhood dermatomyositis. Pediatrics 59, 212\u2013218 (1977).","journal-title":"Pediatrics"},{"key":"4823_CR40","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jpeds.2011.11.057","volume":"160","author":"B Arabshahi","year":"2012","unstructured":"Arabshahi, B., Silverman, R. A., Jones, O. Y. & Rider, L. G. Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis. J. Pediatr. 160, 520\u2013522 (2012).","journal-title":"J. Pediatr."},{"key":"4823_CR41","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S0022-3476(05)80686-9","volume":"117","author":"RJ Hernandez","year":"1990","unstructured":"Hernandez, R. J., Keim, D. R., Sullivan, D. B., Chenevert, T. L. & Martel, W. Magnetic resonance imaging appearance of the muscles in childhood dermatomyositis. J. Pediatr. 117, 546\u2013550 (1990).","journal-title":"J. Pediatr."},{"key":"4823_CR42","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1136\/adc.69.2.232","volume":"69","author":"F De Benedetti","year":"1993","unstructured":"De Benedetti, F., De Amici, M., Aramini, L., Ruperto, N. & Martini, A. Correlation of serum neopterin concentrations with disease activity in juvenile dermatomyositis. Arch. Dis. Child. 69, 232\u2013235 (1993).","journal-title":"Arch. Dis. Child."},{"key":"4823_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1399-0039.1983.tb00371.x","volume":"21","author":"JM Friedman","year":"1983","unstructured":"Friedman, J. M. et al. Immunogenetic studies of juvenile dermatomyositis. HLA antigens in patients and their families. Tissue Antigens 21, 45\u201349 (1983).","journal-title":"Tissue Antigens"},{"key":"4823_CR44","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/0190-9622(93)70052-U","volume":"28","author":"GM Kavanagh","year":"1993","unstructured":"Kavanagh, G. M., Colaco, C. B. & Kennedy, C. T. Juvenile dermatomyositis associated with partial lipoatrophy. J. Am. Acad. Dermatol. 28, 348\u2013351 (1993).","journal-title":"J. Am. Acad. Dermatol."},{"key":"4823_CR45","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1542\/peds.100.3.391","volume":"100","author":"DM Eisenstein","year":"1997","unstructured":"Eisenstein, D. M., Paller, A. S. & Pachman, L. M. Juvenile dermatomyositis presenting with rash alone. Pediatrics 100, 391\u2013392 (1997).","journal-title":"Pediatrics"},{"key":"4823_CR46","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.rdc.2021.07.010","volume":"47","author":"RC Fuhlbrigge","year":"2021","unstructured":"Fuhlbrigge, R. C., Schanberg, L. E. & Kimura, Y. CARRA: the childhood arthritis and rheumatology research alliance. Rheum. Dis. Clin. North Am. 47, 531\u2013543 (2021).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"4823_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/rheumatology\/keq261","volume":"50","author":"N Martin","year":"2011","unstructured":"Martin, N. et al. A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years\u2019 experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies. Rheumatology 50, 137\u2013145 (2011).","journal-title":"Rheumatology"},{"key":"4823_CR48","doi-asserted-by":"publisher","first-page":"101565","DOI":"10.1016\/j.joi.2024.101565","volume":"18","author":"J Wang","year":"2024","unstructured":"Wang, J., Frietsch, R., Neuh\u00e4usler, P. & Hooi, R. International collaboration leading to high citations: global impact or home country effect?. J. Informetr. 18, 101565 (2024).","journal-title":"J. Informetr."},{"key":"4823_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2478\/rir-2022-0001","volume":"3","author":"F Halilu","year":"2022","unstructured":"Halilu, F. & Christopher-Stine, L. Myositis-specific antibodies: overview and clinical utilization. Rheumatol. Immunol. Res. 3, 1\u201310 (2022).","journal-title":"Rheumatol. Immunol. Res."},{"key":"4823_CR50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12969-022-00709-3","volume":"20","author":"J Neely","year":"2022","unstructured":"Neely, J., Ardalan, K., Huber, A. & Kim, S. Childhood Arthritis and Rheumatology Research Alliance Investigators. Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registry. Pediatr. Rheumatol. Online J. 20, 50 (2022).","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"4823_CR51","doi-asserted-by":"publisher","first-page":"5513544","DOI":"10.1155\/2021\/5513544","volume":"2021","author":"D Kwiatkowska","year":"2021","unstructured":"Kwiatkowska, D. & Reich, A. The significance of autoantibodies in juvenile dermatomyositis. Biomed. Res. Int. 2021, 5513544 (2021).","journal-title":"Biomed. Res. Int."},{"key":"4823_CR52","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1136\/annrheumdis-2012-202915","volume":"73","author":"C Malattia","year":"2014","unstructured":"Malattia, C. et al. Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis. Ann. Rheum. Dis. 73, 1083\u20131090 (2014).","journal-title":"Ann. Rheum. Dis."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-04823-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-04823-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-04823-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:03:16Z","timestamp":1773046996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-04823-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":52,"alternative-id":["4823"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-04823-w","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}